Semantic Scholar uses AI to extract papers important to this topic.
Myelodysplastic syndromes (MDS) are a heterogeneous group of chronic hematological malignancies characterized by dysplasia… Expand The International Prognostic Scoring System (IPSS) is an important standard for assessing prognosis of primary untreated adult… Expand BACKGROUND
Myelodysplastic syndromes are clinically heterogeneous disorders characterized by clonal hematopoiesis, impaired… Expand BACKGROUND
Drug treatments for patients with high-risk myelodysplastic syndromes provide no survival advantage. In this trial, we… Expand Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders that affect mostly the elderly and have a… Expand Aberrant DNA methylation, which results in leukemogenesis, is frequent in patients with myelodysplastic syndromes (MDS) and is a… Expand PURPOSE
Patients with high-risk myelodysplastic syndrome (MDS) have high mortality from bone marrow failure or transformation to… Expand Despite multiple disparate prognostic risk analysis systems for evaluating clinical outcome for patients with myelodysplastic… Expand Summary. New, diagnostic criteria for the diagnosis of the various myelodysplastic syndromes (MDS) are proposed, and a detailed… Expand Summary. A uniform system of classification and nomenclature of the acute leukaemias, at present lacking, should permit more… Expand